Osco Drug #3490 Durable Medical Equipment & Medical Supplies Location: 892 N Western Ave, Lake Forest, Illinois 60045 Phone: (847) 735-1032 |
Cvs Pharmacy #02902 Durable Medical Equipment & Medical Supplies Location: 520 N Wester Avenue, Lake Forest, Illinois 60045 Phone: (847) 810-5990 |
Northwestern Medical Group Medicare Supplier Location: 900 N. West Moreland Road, Lake Forest, Illinois 60045 Phone: (847) 295-0001 |
Walgreens #21143 Durable Medical Equipment & Medical Supplies Location: 1000 N Westmoreland Rd, Lake Forest, Illinois 60045 Phone: (847) 810-8441 |
Walgreens #528 Durable Medical Equipment & Medical Supplies Location: 296 E Deerpath, Lake Forest, Illinois 60045 Phone: (847) 234-2413 |
News Archive
Novel vaccines for diseases ranging from the flu to HIV highlight a week's worth of biotechnology research at the American Association of Pharmaceutical Scientists' National Biotechnology Conference. Scientists from academia, industry, and government will gather at the Hilton San Francisco Union Square Sunday, May 16 -Thursday, May 20 to share research and advances in biotherapeutics.
The Journal of Alzheimer's Disease is pleased to announce that Mark W. Bondi, PhD, ABPP/CN, Professor of Psychiatry at UC San Diego and Director of the Neuropsychological Assessment Unit at the VA San Diego Healthcare System, has been chosen as the recipient of the 2016 Alzheimer Award presented by the journal in recognition of his outstanding work on the development of a novel and promising method of staging preclinical Alzheimer's disease (AD) based on number of abnormal biomarkers that is predictive of progression to mild cognitive impairment (MCI) and AD.
As the world watches the Vancouver Olympics, researchers at St. Michael's Hospital in Toronto and Children's Hospital Boston have teamed up to monitor and assess potential infectious disease threats to Vancouver during the Winter Games by integrating two independently developed intelligence systems that focus on global infectious diseases; bio.DIASPORA and HealthMap.
Semafore Pharmaceuticals today reported encouraging data from a Phase I dose-escalation trial of SF1126 in patients with relapsed and refractory myeloma. SF1126 is a novel small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival. PI3K is commonly altered in human cancers, making inhibition of the target attractive for cancer therapy.
By a three-to-one vote, regulators approved Express Scripts' plan to purchase Medco, ending an eight-month inquiry into whether the deal would stifle competition in the pharmacy benefits industry.
› Verified 6 days ago